Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1129

1.

Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease.

Belle A, Laurent V, Pouillon L, Baumann C, Orry X, Lopez A, Rousseau H, Bronowicki JP, Peyrin-Biroulet L.

Dig Liver Dis. 2018 Jul 31. pii: S1590-8658(18)30813-2. doi: 10.1016/j.dld.2018.06.024. [Epub ahead of print]

PMID:
30076016
2.

Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

Buchholz BM, Lykoudis PM, Ravikumar R, Pollok JM, Fusai GK.

World J Gastroenterol. 2018 Jul 28;24(28):3171-3180. doi: 10.3748/wjg.v24.i28.3171.

3.

Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.

de Chambrun GP, Nachury M, Funakoshi N, Gerard R, Bismuth M, Valats JC, Panaro F, Navarro F, Desreumaux P, Pariente B, Blanc P.

Eur J Gastroenterol Hepatol. 2018 Jul 26. doi: 10.1097/MEG.0000000000001223. [Epub ahead of print]

PMID:
30052539
4.

How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective.

Yang SK.

Inflamm Intest Dis. 2017 Nov;2(2):95-101. doi: 10.1159/000454712. Epub 2017 Jan 14. Review.

PMID:
30018960
5.

Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.

Park YE, Cheon JH, Park JJ, Kim YJ, Choi CH, Park Y, Park SJ, Kim TI, Kim WH.

Int J Colorectal Dis. 2018 Jul 9. doi: 10.1007/s00384-018-3123-6. [Epub ahead of print]

PMID:
29987360
6.

Common bile duct intussusception during ERCP for stone removal.

Rocha RSP, Minata MK, de Moura DTH, de Moura EGH, Franzini TAP.

VideoGIE. 2017 Nov 8;3(1):28-30. doi: 10.1016/j.vgie.2017.09.003. eCollection 2018 Jan. No abstract available.

7.

Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis.

Nielsen MJ, Thorburn D, Leeming DJ, Hov JR, Nygård S, Moum B, Saffioti F, Gilja OH, Boberg KM, Mazza G, Røsjø H, Pinzani M, Karlsen TH, Karsdal MA, Vesterhus M.

Aliment Pharmacol Ther. 2018 Jul;48(2):179-189. doi: 10.1111/apt.14806. Epub 2018 May 30.

PMID:
29851098
8.

Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.

Tse CS, Loftus EV Jr, Raffals LE, Gossard AA, Lightner AL.

Aliment Pharmacol Ther. 2018 Jul;48(2):190-195. doi: 10.1111/apt.14829. Epub 2018 May 28.

PMID:
29808485
9.

Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-grade Dysplasia in Patients with Inflammatory Bowel Disease.

Kisiel JB, Klepp P, Allawi HT, Taylor WR, Giakoumopoulos M, Sander T, Yab TC, Moum BA, Lidgard GP, Brackmann S, Mahoney DW, Roseth A, Ahlquist DA.

Clin Gastroenterol Hepatol. 2018 May 15. pii: S1542-3565(18)30490-7. doi: 10.1016/j.cgh.2018.05.004. [Epub ahead of print]

PMID:
29775793
10.

Phenotype and Clinical Course of Inflammatory Bowel Disease With Co-existent Celiac Disease.

Tse CS, Deepak P, De La Fuente J, Bledsoe AC, Larson JJ, Murray JA, Papadakis KA.

J Crohns Colitis. 2018 Jul 30;12(8):973-980. doi: 10.1093/ecco-jcc/jjy061.

PMID:
29741603
11.

Colorectal Cancer in Inflammatory Bowel Disease.

Stidham RW, Higgins PDR.

Clin Colon Rectal Surg. 2018 May;31(3):168-178. doi: 10.1055/s-0037-1602237. Epub 2018 Apr 1. Review.

PMID:
29720903
12.

In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study.

Mehta K, Jaiswal P, Briggs F, Faubion WA, Tabibian JH, Cominelli F, Dave M.

Sci Rep. 2018 May 1;8(1):6825. doi: 10.1038/s41598-018-24060-4.

13.

Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.

Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 7. Review.

14.

The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.

Khan N, Trivedi C, Shah Y, Cole E, Lewis J, Yang YX.

Inflamm Bowel Dis. 2018 Apr 25. doi: 10.1093/ibd/izy106. [Epub ahead of print]

PMID:
29697792
15.

Amyloidoma of Stomach: A Case Report.

Savant D, Adler M, Kahn L, Cocker R.

Acta Cytol. 2018;62(3):231-233. doi: 10.1159/000488133. Epub 2018 Apr 25.

PMID:
29694947
16.

Natural history and outcome of inflammatory bowel diseases in children in Saudi Arabia: A single-center experience.

Alreheili KM, Alsaleem KA, Almehaidib AI.

Saudi J Gastroenterol. 2018 May-Jun;24(3):171-176. doi: 10.4103/sjg.SJG_490_17.

17.

High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients.

Girardin M, Hadengue A, Frossard JL; Swiss IBD Cohort Study Group.

World J Clin Cases. 2018 Apr 16;6(4):44-53. doi: 10.12998/wjcc.v6.i4.44.

18.

Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.

Dubinsky MC, Cross RK, Sandborn WJ, Long M, Song X, Shi N, Ding Y, Eichner S, Pappalardo B, Ganguli A, Wang A.

Inflamm Bowel Dis. 2018 Apr 13. doi: 10.1093/ibd/izy065. [Epub ahead of print]

PMID:
29668916
19.

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.

Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, Chazouilleres O, Duvoux C, Dumortier J, Leroy V, Treton X, Durand F, Dharancy S, Nachury M, Goutorbe F, Lamblin G, Boivineau L, Peyrin-Biroulet L, Pageaux GP.

Dig Liver Dis. 2018 Jul;50(7):668-674. doi: 10.1016/j.dld.2018.02.014. Epub 2018 Mar 13.

PMID:
29655972
20.

Supplemental Content

Loading ...
Support Center